GI
BMY icon

GAMMA Investing’s Bristol-Myers Squibb BMY Stock Holding History

GAMMA Investing’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.52M Buy
56,369
+4,042
+8% +$255K 0.12% 132
2026
Q2 		$3.02M Sell
52,327
-1,556
-3% -$89.3K 0.11% 144
2026
Q1 		$3.27M Buy
53,883
+11,854
+28% +$691K 0.15% 102
2025
Q4 		$2.27M Buy
42,029
+3,814
+10% +$183K 0.11% 151
2025
Q3 		$1.72M Sell
38,215
-2,293
-6% -$107K 0.1% 178
2025
Q2 		$1.88M Buy
40,508
+823
+2% +$40.4K 0.12% 153
2025
Q1 		$2.42M Buy
39,685
+6,267
+19% +$365K 0.18% 94
2024
Q4 		$1.89M Buy
33,418
+6,032
+22% +$337K 0.16% 108
2024
Q3 		$1.42M Buy
27,386
+10,410
+61% +$488K 0.14% 139
2024
Q2 		$705K Sell
16,976
-448
-3% -$20K 0.1% 190
2024
Q1 		$945K Buy
17,424
+4,348
+33% +$221K 0.19% 89
2023
Q4 		$639K Buy
+13,076
New +$686K 0.17% 94

Other funds holding BMY

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
BFA
Benedict Financial Advisors Atlanta, Georgia $504M AUM 20.67% 1-Year Est. Return
BE
Bonness Enterprises Washington, District of Columbia $307M AUM 22.88% 1-Year Est. Return

GAMMA Investing's BMY Position: Q3 2026 in Review

GAMMA Investing increased its Bristol-Myers Squibb (BMY) stake by 7.7% in Q3 2026, buying an estimated $255K and bringing the position to 56,369 shares worth $3.52M. The position accounts for 0.12% of the portfolio, ranked #132.

GAMMA Investing first reported a position in BMY in Q4 2023 and has held it in 12 quarters since. 86 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • GAMMA Investing held 56,369 shares of Bristol-Myers Squibb worth $3.52M as of Q3 2026.
  • GAMMA Investing bought 4,042 Bristol-Myers Squibb shares in Q3 2026, an estimated $255K.
  • Bristol-Myers Squibb made up 0.12% of GAMMA Investing's portfolio in Q3 2026, its #132 holding.
  • GAMMA Investing first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 12 quarters since.
  • 86 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.